TIP_link_300x300.jpg
Flexible Electronics Market Size Worth $57.69 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners
September 25, 2024 07:36 ET | The Insight Partners
US & Canada, Sept. 25, 2024 (GLOBE NEWSWIRE) -- According to a new comprehensive report from The Insight Partners, the global flexible electronics market is observing significant growth owing to...
22157.jpg
Water and Wastewater Treatment Market Forecast to 2033: Rising Demand for Energy-efficient and Advanced Water Treatment Technologies Driving Opportunities
September 25, 2024 07:30 ET | Research and Markets
Dublin, Sept. 25, 2024 (GLOBE NEWSWIRE) -- The "Water and Wastewater Treatment Market by Type, Offering, Application, and Geography - Global Forecast to 2033" report has been added to ...
Future Market Insights.png
Global Plastic Sleeve Market to Surge towards USD 15.4 Billion by 2034: Booming Food Delivery, Customization, and Sustainable Innovations Fuel Industry Growth amid Environmental Challenges | Future Market Insights, Inc.
September 25, 2024 07:30 ET | Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Sept. 25, 2024 (GLOBE NEWSWIRE) -- The global plastic sleeve market is on track to reach an impressive valuation of USD 9.8 billion by 2024, with projections indicating a robust...
Titan Medical.jpg
Proxy Deadline Thursday September 26, 2024
September 25, 2024 07:30 ET | Titan Medical Inc.
TORONTO, Ontario, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) released a reminder for shareholders to vote ahead of Titan’s annual and special shareholders...
ACASTI_Logo.jpg
Acasti Announces Completion of Patient Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial of GTX-104
September 25, 2024 07:30 ET | Acasti Pharma, Inc.
PRINCETON, N.J., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel injectable formulation of...
Logo.png
LuxUrban Hotels to Host Webcast to Review the Financial Results for the Second Quarter of 2024
September 25, 2024 07:30 ET | LuxUrban Hotels Inc.
LuxUrban Hotels to Host Webcast to Review the Financial Results for the Second Quarter of 2024
OCUL Logo.jpg
Ocular Therapeutix™ to Present at the UBS Virtual Opthalmology Day 2024
September 25, 2024 07:30 ET | Ocular Therapeutix, Inc.
BEDFORD, Mass., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to improving vision in the real world...
PurposeLogos-K_RGB.png
Purpose Investments Inc. Announces Final September 2024 Distribution Rate for Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fund
September 25, 2024 07:30 ET | Purpose Investments Inc.
TORONTO, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Purpose Investments Inc. announced today the final September 2024 distribution rates for Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose...
Amedisys Logo.jpg
Amedisys has earned the 2023 SHPBest™ Patient Satisfaction Awards
September 25, 2024 07:30 ET | Amedisys, Inc.
BATON ROUGE, La., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, has 92 home health and hospice care...
InflaRx on large white.jpg
InflaRx Presents Post Hoc Analysis of SHINE Trial of Vilobelimab in Hidradenitis Suppurativa at the 2024 European Academy of Dermatology and Venereology Congress
September 25, 2024 07:30 ET | InflaRx N.V.
JENA, Germany, Sept. 25, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced...